<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Glomerulonephritis classification schema with C4 glomerulopathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Glomerulonephritis classification schema with C4 glomerulopathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Glomerulonephritis classification schema with C4 glomerulopathy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Complement-mediated glomerulonephritis, that is, glomerulonephritis characterized by predominant deposition of complement factors with little or no immunoglobulin (Ig) can therefore be further subdivided into C3 glomerulopathy and C4 glomerulopathy. C3 glomerulopathy is characterized by bright staining for C3 with minimal or no immunoglobulin. However, C4 glomerulopathy is characterized by bright staining for C4d with minimal or no immunoglobulin. The difference in C4 glomerulopathy and C3 glomerulopathy lies in the essentially absent or minimal staining for C3 in C4 glomerulopathy. Why there is no staining for C3, because activation of C4 should presumably lead to the formation of C4 convertase and activation of C3, is not known at this time.</div><div class="graphic_footnotes">GBM: glomerular basement membrane; DDD: dense deposit disease; GN: glomerulonephritis.</div><div class="graphic_reference">Reproduced from: Sethi S, Quint PS, O'Seaghdha CM, et al. C4 glomerulopathy: A disease entity associated With C4d deposition. Am J Kidney Dis 2016. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 107060 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
